Your session is about to expire
← Back to Search
Device
Use of Stable Airway Management Device in Monitored Anesthesia Care
N/A
Waitlist Available
Led By Visnal Yajnik, MD
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 hours
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new device called the Stable Airway Management (SAM) device. It is designed to keep a patient's head and airway steady during procedures that require anesthesia. The study will evaluate the effectiveness of this new device.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 6 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 hours
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of Subjects Converted From MAC to General Anesthesia
Total Apneic Events /Total Number Requiring Airway Manipulation
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
An investigational device will be used to hold patient's head and airway in a stable position.
Group II: Standard of careActive Control1 Intervention
Pillows and towels will be used to hold patient's head and airway in a stable position.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Stable airway management (SAM) device
2022
N/A
~40
Find a Location
Who is running the clinical trial?
Virginia Commonwealth UniversityLead Sponsor
717 Previous Clinical Trials
22,895,658 Total Patients Enrolled
Visnal Yajnik, MDPrincipal InvestigatorVirginia Commonwealth University